APA (7th ed.) Citation

Schneeweiss, A., Marmé, F., & Sinn, P. (2011). A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer. Annals of oncology, 22(3), .

Chicago Style (17th ed.) Citation

Schneeweiss, Andreas, Frederik Marmé, and Peter Sinn. "A Randomized Phase II Trial of Doxorubicin Plus Pemetrexed Followed by Docetaxel Versus Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Treatment of Early Breast Cancer." Annals of Oncology 22, no. 3 (2011).

MLA (9th ed.) Citation

Schneeweiss, Andreas, et al. "A Randomized Phase II Trial of Doxorubicin Plus Pemetrexed Followed by Docetaxel Versus Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Treatment of Early Breast Cancer." Annals of Oncology, vol. 22, no. 3, 2011.